INS and type 2 diabetes mellitus: The host immune response to active TB disease results in a prolonged state of systemic inflammation characterized by activation of various immune cells by binding with PAMPs through the TLRs resulting in elevated levels of pro-inflammatory cytokines like IL-1β and IL-6 which are known to directly inhibit insulin-stimulated glucose uptake and thus implicated in the etiology of type 2 diabetes.